[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Garvey W.T., Batterham R.L., Bhatta M., Buscemi S., Christensen L.N., Frias J.P., Jodar E., Kandler K., Rigas G., Wadden T.A., et al
Covering drugs that can cost hundreds of dollars per patient every month only pays off if patients stay on therapy
doi:10.1080/08998280.2025.2456441
Razia Hashmi, the associations vice president of clinical affairs
The phase 3 TRIUMPH trial results, announced more recently, showed even longer-term data
The results showed that during the 16-week treatment period, patients who received the highest dosage (120 mg twice daily) of danuglipron experienced an average reduction in HbA1c of 1.16 percentage points and a weight loss of 4.17 kilograms